Webinars

Tutors

• Mrs Aine Liggett
  Northern Ireland Medicines and Poisons Advice Service
• Ms Siobhan Kelly
  Lead Nurse for Yellow Card Centre Northern Ireland

Aim

To promote the importance of healthcare professionals reporting adverse events to the MHRA’s Yellow Card scheme to improve patient safety.

Learning outcomes

Having completed this webinar you will be able to:

• Describe the role of the NI Yellow Card Centre
• Understand the benefits of reporting via the Yellow Card scheme
• List the range of products for which safety issues should be reported
• Define the information to be reported within a Yellow Card report
• Report relevant adverse events within your professional practice.

Tutors

• Mrs Aine Liggett
  Northern Ireland Medicines and Poisons Advice Service
• Ms Siobhan Kelly
  Lead Nurse for Yellow Card Centre Northern Ireland

Aim

To promote the importance of healthcare professionals reporting adverse events to the MHRA’s Yellow Card scheme to improve patient safety.

Learning outcomes

Having completed this webinar you will be able to:

• Describe the role of the NI Yellow Card Centre
• Understand the benefits of reporting via the Yellow Card scheme
• List the range of products for which safety issues should be reported
• Define the information to be reported within a Yellow Card report
• Report relevant adverse events within your professional practice.

Tutors

• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Joy Watson
  Addictions Consultant, BHSCT
• Ms Caren Walsh
  General Practitioner, Medical Adviser SPPG and QI Lead Primary Care
• Ms Lisa Byers
  Controlled Drugs DoH (CDAO)
• Ms Emma McDowell
  Lead pharmacist for Pain Management Deprescribing, NHSCT

Aim

To provide a discussion forum exploring the misuse / dependence of Gabapentinoids in society.

Learning outcomes

Having completed this webinar, you will be able to:

• Define the terms misuse and dependence
• Recognise the risks associated with Gabapentinoids use and the signs of misuse and dependence
• Consider reduction strategies to help prevent / reduce the abuse of Gabapentinoids in primary care settings
• Provide support to patients who have developed issues of dependence when using Gabapentinoids
• Share your knowledge with colleagues to promote the safe and effective supply and use of Gabapentinoids in practice.